Radiofrequenzablation bei Barrett-Syndrom – Schritt für Schritt

Die Behandlung von Barrett-Ösophagus und Barrett-Frühkarzinom ist eine Domäne der endoskopischen organerhaltenden Therapie geworden. Eine Kombination von endoskopischer Resektion und ablativen Verfahren hat hier die besten Ergebnisse gezeigt. Unter den ablativen Verfahren ist die Radiofrequenzablation (RFA) aufgrund guter Ergebnisse und einfacher Handhabung auch bei großen Ablationsarealen als das Standardverfahren anzusehen.

Schlüsselwörter

Barrett-Ösophagus - Barrett-Frühkarzinom - Radiofrequenzablation - Ablationskatheter

• Literatur

• 1 Dubecz A, Solymosi N, Stadlhuber RJ. et al. Does the incidence of adenocarcinomas of the esophagus and the gastric cardia continue to rise in the twenty-first century? – A SEER database analysis. J Gastrointest Surg 2014; 18: 124-129
• 2 Hur C, Miller M, Kong CY. et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013; 119: 1149-1158
• 3 Pech O, Behrens A, May A. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrettʼs esophagus. Gut 2008; 57: 1200-1206
• 4 Phoa KN, Pouw RE, Bisschops R. et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut 2016; 65: 555-562
• 5 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrettʼs esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
• 6 Phoa KN, van Vilsteren FG, Weusten B. et al. Radiofrequency ablation vs. endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia. JAMA 2014; 311: 1209-1217
• 7 Duits LC, Phoa KN, Curvers WL. et al. Barrettʼs esophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Gut 2015; 64: 700-706
• 8 Desai TK, Krishnan K, Samala N. et al. The incidence of esophageal adenocarcinoma in non-dysplastic Barrettʼs esophagus: a meta-analysis. Gut 2012; 61: 970-976
• 9 Smith CD, Bejarano PA, Melvin WS. et al. Endoscopic ablation of intestinal metaplasia containing high grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007; 21: 560-569
• 10 Künzli HT, Schölvinck DW, Phoa KN. et al. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrettʼs esophagus. Endoscopy 2015; 47: 592-597
• 11 Pouw RE, Künzli HAT, Bisschops R. et al. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrettʼs oesophagus: a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2018; 3: 566-574
• 12 Cotton CC, Wolf WA, Pasricha S. et al. Recurrent intestinal metaplasia after radiofrequency ablation for Barrettʼs esophagus: endoscopic findings and anatomic location. Gastrointest Endosc 2015; 81: 1362-1369
• 13 Phoa KN, Pouw RE, van Vilsteren FG. et al. Remission of Barrettʼs esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104
• 14 Gupta M, Iyer PG, Lutzke L. et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrettʼs esophagus: results from a US Multicenter Consortium. Gastroenterology 2013; 145: 79-86
• 15 Komanduri S, Kahrilas PJ, Krishnan K. et al. Recurrence of Barrettʼs esophagus is rare following endoscopic eradication therapy coupled with effective reflux protocol. Am J Gastroenterol 2017; 112: 556-566
• 16 Shaheen NJ, Sharma P, Overholt BF. et al. Radiofrequency ablation in Barrettʼs esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
• 17 Cotton CC, Haidry R, Thrift AP. et al. Development of evidence-based surveillance intervals after radiofrequency ablation of Barrettʼs esophagus. Gastroenterology 2018; 155: 316-326
• 18 Qumseya BJ, Wani S, Desai M. et al. Adverse events after radiofrequency ablation in patients with Barrettʼs esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 1086-1095